comparemela.com

Latest Breaking News On - சவுதி மருத்துவ இதழ் - Page 1 : comparemela.com

Are There Really Any Benefits to Drinking Ginger Water?

Are There Really Any Benefits to Drinking Ginger Water?
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

CID1418 Patient Safety and Quality Improvement : Health Care System

Question: Healthcare quality initiatives can include such things as improved patient care, electronic health record management/ implementation, clinical equipment upgrades, and facilities upgrades. Describe a time when you or someone you know were part of a healthcare quality initiative. Explain what the quality initiative was, and what was not working well with the current process/procedure (i.e., the improvement opportunity the quality initiative sought to address). What were the goals of the project? What were the outcomes of the quality improvement project? Were all of the goals met? Explain how “success” was measured.  Answer: Introduction: Health care costs have been increasing at an alarming rate worldwide; however, the quality of patient-centric care remains the same. Patient-centric care is one of the crucial part of the health care system, which aid in achieving the success of the health care system, patient outcome and reducing the global burden of disease. Theref

MENA Biologics & Biosimilars Market to Surpass US$ 623 7 by 2027, Says Coherent Market Insights (CMI)

US$ 442.5 million in 2020 and is expected to exhibit a CAGR of 3.9% during the forecast period (2020-2027). Key Trends and Analysis: The MENA biologics & biosimilars market is expected to witness significant growth, owing to increasing prevalence of Age-related Macular Degeneration (AMD). For instance, according to the study in Saudi Medical Journal 2015, in Saudi Arabia, AMD represents 3.3% of the major causes of blindness in individuals older than 50 years. The increasing approval and new drug launches are expected to propel the market growth. For instance, in 2017, Swedish Orphan Biovitrum AB (Sobi) received Saudi Food & Drug Authority (SFDA) approval for Elocta (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life, for the treatment of hemophilia A.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.